FA-2025-000058 - [2025] EWHC 2685 (Fam)

Dr. Seal’s first report dated 4^th November 2019

Dr. Barrett advised that the Applicant should obtain an endocrinology assessment with Dr. Seal, a Consultant Endocrinologist at the Tavistock Clinic. Dr. Seal advised that the Applicant’s function had reached a range suitable for testosterone therapy. He suggested that the Applicant commence on “Testogel 16.2 mg/g, 2 applications once a day”, a testosterone replacement therapy gel.

As stated above, the Applicant then commenced testosterone therapy on 15^th November 2019, which he continued until April 2020. While the Panel states that “Dr Seal’s report makes no mention of [the Applicant] wanting to conceive”, I agree with Ms Sarathy that given the Applicant’s openness throughout the investigations, that is not to be inferred as his having been disingenuous with Dr. Seal but entirely explained by the fact that Dr. Seal’s focus was concentrated on an unrelated area of expertise.